SR One Capital Management’s Odyssey Therapeutics ODTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ODTX
SR One Capital Management's ODTX Position: Q3 2026 in Review
SR One Capital Management held its Odyssey Therapeutics (ODTX) position steady in Q3 2026 at 3,794,883 shares worth $84.3M. The position accounts for 7.34% of the portfolio, ranked #6.
SR One Capital Management first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.
- SR One Capital Management held 3,794,883 shares of Odyssey Therapeutics worth $84.3M as of Q3 2026.
- SR One Capital Management left its Odyssey Therapeutics share count unchanged in Q3 2026.
- Odyssey Therapeutics made up 7.34% of SR One Capital Management's portfolio in Q3 2026, its #6 holding.
- SR One Capital Management first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 73 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.
Based on SR One Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.